AST Spacemobile, Inc. current report, 14 August 2023

AST SpaceMobile, Inc. — Form 8-K Summary

Reporting date: August 14, 2023. The filing reports entry into two loan agreements and the creation of related financial obligations. It does not provide quarterly operating results or a financial statement update.

Material Financing Transactions

  • Atlas Credit Facility: AST & Science, LLC entered into a senior secured term loan facility with total commitments of up to $100.0 million.
  • Initial borrowing: The company borrowed $48.5 million at closing. An additional $51.5 million may be borrowed only if the company raises additional equity capital and obtains sufficient insurance coverage.
  • Interest and maturity: The initial borrowing bears interest at a fixed annual rate of 14.75%, payable quarterly, and matures on August 14, 2026. Mandatory prepayments may apply upon specified events.
  • Net proceeds: The company received approximately $37.3 million after $2.0 million of placement-agent fees and offering expenses, a $1.8 million interest-reserve escrow deposit, and $7.4 million of prepaid insurance premiums.
  • Collateral and covenants: The Atlas facility is secured by substantially all company and subsidiary assets other than assets of certain excluded subsidiaries. It includes liquidity requirements and restrictions on additional indebtedness, restricted payments, and asset dispositions.
  • Lone Star Loan: AST LLC and certain subsidiaries entered into a $15.0 million term loan commitment secured by specified real property fixtures and equipment at a Texas facility.
  • Lone Star terms: Interest accrues at the Prime Rate plus 0.75%, subject to a ceiling rate. Principal payments begin April 14, 2025, are scheduled in 48 equal monthly installments, and the loan matures January 14, 2029. Interest payments begin August 14, 2024.
  • Cash support: The company deposited $15.0 million into a Lone Star money market fund. The deposit may become restricted cash if consolidated cash and cash equivalents fall below $75.0 million and may be used to offset loan obligations if cash falls below $50.0 million.

Financial Metrics and Liquidity

  • The filing does not provide revenue, net income, operating cash flow, margins, cash balances, or comparative-period financial results.
  • The transactions increase committed debt by up to $115.0 million, although only $48.5 million was initially borrowed under the Atlas facility and the filing does not clearly state whether any amount was drawn under the Lone Star commitment at closing.
  • Atlas proceeds are intended for general corporate purposes permitted under the credit agreement.
  • The financing arrangements impose liquidity requirements and may restrict the company’s financial and operational flexibility.

Outlook, Risks, and Unusual Items

  • Management did not provide formal financial guidance in this filing.
  • The company identifies risks related to financing its research and development activities, liquidity, cash flows, capital expenditures, commercial partnerships, regulatory approvals, competition, and commercialization of the SpaceMobile service.
  • Planned testing of the BlueWalker3 satellite could be delayed or unsuccessful because of connectivity loss, satellite destruction, communication failures, or required modifications. Testing issues could cause material additional costs, delay commercialization, and make future capital raising more difficult.
  • Future borrowings under the Atlas facility depend on additional equity financing and insurance coverage.
  • The Lone Star agreement includes negative covenants, including a requirement to retain the current Chief Executive Officer.

Most Important Facts to Verify

  • Whether the full $48.5 million Atlas borrowing was received net of all disclosed deductions and how the proceeds were allocated.
  • Whether any portion of the $15.0 million Lone Star commitment was drawn at closing.
  • The company’s cash and cash-equivalent balance relative to the $75.0 million and $50.0 million thresholds under the Lone Star agreement.
  • Compliance with Atlas liquidity tests, collateral requirements, and other restrictive covenants.
  • The effective interest expense and potential refinancing or repayment requirements before the August 2026 and January 2029 maturities.
  • Progress and results of BlueWalker3 testing and the resulting implications for commercialization and future capital needs.